Conference Call Participants
Jiale Song – Jefferies LLC, Research Division
Presentation
Jiale Song
Jefferies LLC, Research Division
All right. Welcome, everyone, to Jefferies 2026 Global Healthcare Conference. My name is Roger Song, senior analyst cover SMID-Cap biotech. It’s my great pleasure to have the fireside chat with our next company, United Therapeutics. We have James, CFO; and then Harry from IR. Good to see you, gentlemen.
James Edgemond
CFO & Treasurer
Great, Roger, thank you. Thanks for inviting Harry and I, and we appreciate the time we’ve had great meetings this morning.
Jiale Song
Jefferies LLC, Research Division
Excellent. Excellent to hear. So — and I’m very happy to have you here as well. So maybe, James, if you want to do like a quick state of art for UTHR because you just gave us a fantastic data at the ATS from TETON and then ralinepag. I think UTHR is in a very good position to — for the next stage of the growth. And then yes, give us some high level and then we can have a conversation.
James Edgemond
CFO & Treasurer
Yes, you bet, Roger. Thanks. Harry is going to do real quickly our forward-looking statements as always, and I’ll do an overview.
Harrison Silvers
Manager of Investor Relations
Yes. Thanks for having us, Roger. Thanks for everybody in the room and online listening in as well. Today, we may make some forward-looking statements. And for any risks and uncertainties associated with those statements, I would encourage you to look at our latest SEC filings on Forms 10-K and 10-Q.
James Edgemond
CFO & Treasurer
Great. Thanks, Harry. And thanks